What is the recommended protocol for stopping Contrave (bupropion and naltrexone)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Protocol for Stopping Contrave (Naltrexone/Bupropion)

When discontinuing Contrave (naltrexone/bupropion), a gradual tapering approach is recommended rather than abrupt discontinuation to minimize potential withdrawal symptoms.

Recommended Discontinuation Protocol

Indications for Discontinuation

  • Lack of efficacy: Discontinue if patient has not lost at least 5% of total body weight after 12 weeks at maintenance dose 1
  • Development of significant side effects
  • Need for opioid therapy (e.g., upcoming surgical procedures)
  • Development of contraindications:
    • Uncontrolled hypertension
    • Seizure disorders
    • Pregnancy 2

Tapering Schedule

  1. Week 1-2: Reduce from full maintenance dose (2 tablets twice daily) to 1 tablet twice daily
  2. Week 3-4: Reduce to 1 tablet daily in the morning
  3. Week 5: Complete discontinuation

Special Considerations

For Patients Requiring Opioid Therapy

  • Discontinue Contrave at least 7-10 days before scheduled procedures requiring opioid analgesia 1, 2
  • This timeframe allows for clearance of naltrexone to prevent:
    • Reduced efficacy of opioid analgesics
    • Potential precipitation of withdrawal in patients on chronic opioids

For Patients with Hepatic or Renal Impairment

  • For moderate to severe hepatic impairment: Use a more gradual tapering schedule (extend each step to 2 weeks) 1
  • For moderate to severe renal impairment: Taper from the reduced maintenance dose (1 tablet twice daily) 1

Monitoring During Discontinuation

Vital Signs

  • Monitor blood pressure and heart rate weekly during tapering
  • Bupropion can affect blood pressure; changes may occur during discontinuation 1, 2

Mood and Mental Health

  • Assess for changes in mood, particularly in patients with history of depression
  • Bupropion has antidepressant properties; discontinuation may unmask depression 1, 2
  • Monitor for emergence of suicidal thoughts, especially during the first 1-2 weeks of tapering 2

Weight Management

  • Discuss alternative weight management strategies before discontinuation
  • Consider transition to another weight management medication if appropriate
  • Emphasize continued lifestyle modifications to maintain weight loss 1

Managing Discontinuation Side Effects

Common Discontinuation Symptoms

  • Headaches
  • Irritability
  • Insomnia or increased sleep
  • Fatigue
  • Mild anxiety

Management Approaches

  • Slow the tapering schedule if significant symptoms occur
  • Consider temporary symptomatic treatment for specific symptoms (e.g., sleep aids for insomnia)
  • Ensure adequate hydration and regular physical activity to minimize symptoms

Post-Discontinuation Follow-Up

  • Schedule follow-up appointment 2-4 weeks after complete discontinuation
  • Assess weight maintenance, mood, and overall health status
  • Reinforce ongoing lifestyle modifications for weight management

Contraindications to Abrupt Discontinuation

  • History of seizure disorders (increased risk with abrupt bupropion discontinuation)
  • Current major depressive disorder
  • Concurrent use of other medications that affect dopamine, norepinephrine, or serotonin systems 2

Following this structured tapering protocol helps minimize potential withdrawal effects and allows for appropriate monitoring of patients during the discontinuation process.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Depression and Weight in High-Risk Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.